Walgreens Boots Alliance (WBA) has recently announced that its shareholders have approved the acquisition of the company by entities affiliated with Sycamore Partners Management. The Special Meeting of Shareholders saw approximately 96% of votes cast in favor of the merger agreement proposal, with around 95% of unaffiliated shareholders voting in favor as well.
Under the terms of the Merger Agreement, WBA shareholders will receive $11.45 per share in cash at closing, along with a non-transferable Divested Asset Proceeds Right that could potentially result in an additional $3.00 per share from the future monetization of WBA’s interests in VillageMD. This includes the Village Medical, Summit Health, and CityMD businesses.
The transaction is expected to close in the third or fourth quarter of calendar year 2025, subject to customary closing conditions and regulatory approvals. This move marks a significant development for both WBA and Sycamore Partners Management, as they work towards finalizing the acquisition.
This news was first reported on TheFly, a leading source for real-time, market-moving financial news. For more updates on the best-performing stocks, you can visit TipRanks.
For more information on WBA and related topics, you can refer to the Disclaimer & Disclosure and Report an Issue sections on TipRanks.
Overall, the approval of the acquisition by WBA shareholders is a positive step towards the company’s future growth and strategic direction. Stay tuned for more updates on this evolving story.
